Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2023 | 12-2022 | 09-2022 | |
Operating Expenses | 39,168 | 0 | 30,602 |
Operating Income | -39,168 | N/A | -30,602 |
Other Income | 3,543 | 0 | 1,258 |
Pre-tax Income | -35,625 | 0 | -29,344 |
Net Income Continuous | -35,625 | N/A | -29,344 |
Net Income | $-35,625 | $N/A | $-29,344 |
EPS Basic Total Ops | -1.22 | N/A | -1.06 |
EPS Basic Continuous Ops | -1.22 | N/A | -1.06 |
EPS Diluted Total Ops | -1.22 | N/A | -1.06 |
EPS Diluted Continuous Ops | -1.22 | N/A | -1.06 |
EBITDA(a) | $-39,902 | $N/A | $-30,602 |